Also , as I believe I read somewhere before , that Dendreon's Cancer Treatment ( PROVENGE ) was being considered for a Medicare rebate in the USA.
If/When PRR & it's Cvac trial , is succesful , then you would imagine the same rule of thumb would apply .
This not only realises the ultimate goal of saving lives and as a bonus , cheaper for patients , it also makes Cvac the go to drug & therefore increased revenue.
http://www.cvac.ae/ game on!, page-33
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.010(3.17%) |
Mkt cap ! $443.6M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.8¢ | 30.5¢ | $1.050M | 3.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 334744 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 5285 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |